跳至主要内容
临床试验/NCT01219946
NCT01219946已完成不适用

A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express the Symptoms of Chronic Obstructive Pulmonary Disease and the Limitations of Patients' Activities in Primary Care.

AstraZeneca1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2010年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
700
试验地点
1
主要终点
Words used by the patients and the physicians to express the symptoms of COPD as well as the limitations of patients' daily living activities caused by COPD.

研究概览

简要总结

Chronic obstructive pulmonary disease (COPD) is characterized by a progressive decline in lung function and increased symptoms such as breathlessness/dyspnoea, cough and expectoration.

Even though subjective in nature, the symptomatology of COPD and mainly that of breathlessness/dyspnoea has been studied with the use of objective measurement tools. Taking into consideration that the symptoms experienced by the patient who suffers from a progressive disease such as COPD can only be perceived and interpreted by the patient him- or herself, and thus difficult to be quantified, COPD remains a challenge in clinical research.

Therefore, there is a need to carry out qualitative studies that will provide insight into the wide spectrum of COPD symptomatology from the patient's perspective. In addition, a further mapping of the impact that COPD symptoms' perception has on a patient's life is required, as well as of the different pathways through which symptoms' perception is interpreted regarding the limitations of daily living activities, and the subsequent impact on disease management. The more the physician learns on the embodied experience of COPD, the better he/she may assist the patient in achieving optimal COPD management.

Thus this cross-sectional observational study was designed aiming to obtain these data. Specifically, the study aims to evaluate the most frequently used words by the patients and the physicians to express the symptoms of COPD as well as the limitation of activities that it causes.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
45 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Aged 45-75 years
  • Current or former smokers
  • Known history of COPD for at least 6 months before enrolment into the study documented by spirometry (FEV1 /FVC <70%)
  • Patients with stable COPD (no exacerbation within the last month before enrolment into the study) under treatment with a long-acting inhaled bronchodilator (LABA and/or LAMA) alone or in combination with an inhaled corticosteroid
  • Written consent for participation in the study
  • Patients who are able to complete by themselves in Greek a questionnaire on COPD.

排除标准

  • Patients with diagnosed Asthma
  • Patients with any psychiatric, neurological or other disorder render them unable to complete the COPD questionnaire by themselves
  • The patient participates in another study.

结局指标

主要结局

Words used by the patients and the physicians to express the symptoms of COPD as well as the limitations of patients' daily living activities caused by COPD.

时间窗: End of recruitment (estimated timeframe :2.5 months)

次要结局

  • Age(End of recruitment (estimated timeframe :2.5 months))
  • Gender(End of recruitment (estimated timeframe :2.5 months))
  • Place of residence(End of recruitment (estimated timeframe :2.5 months))
  • Marital status(End of recruitment (estimated timeframe :2.5 months))
  • Native language(End of recruitment (estimated timeframe :2.5 months))
  • Educational level(End of recruitment (estimated timeframe :2.5 months))
  • Occupation(End of recruitment (estimated timeframe :2.5 months))
  • Co-morbidities(End of recruitment (estimated timeframe :2.5 months))
  • Years / months since COPD diagnosis and years with COPD symptoms(End of recruitment (estimated timeframe :2.5 months))
  • Smoking history(End of recruitment (estimated timeframe :2.5 months))
  • Number of exacerbations during the last year(End of recruitment (estimated timeframe :2.5 months))
  • Current therapy(End of recruitment (estimated timeframe :2.5 months))
  • CCQ score(End of recruitment (estimated timeframe :2.5 months))
  • Compliance with therapy(End of recruitment (estimated timeframe :2.5 months))
  • Actions/therapeutic recommendations by the physician associated with each chosen word that express the chronic daily symptoms(End of recruitment (estimated timeframe :2.5 months))
  • Scale for the assessment of the severity of the relevant symptoms(End of recruitment (estimated timeframe :2.5 months))
  • Actions/therapeutic recommendations by the physician when any of the symptoms worsen(End of recruitment (estimated timeframe :2.5 months))
  • Severity scale regarding how the patient experiences each of the chosen words that express the chronic daily symptoms(End of recruitment (estimated timeframe :2.5 months))
  • Related actions initiated by the patient regarding chronic daily symptoms(End of recruitment (estimated timeframe :2.5 months))
  • Related actions initiated by the patient when the symptoms worsen.(End of recruitment (estimated timeframe :2.5 months))

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验